What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Surgery
Her scientific interests lie mostly in Surgery, Radiation therapy, Lung cancer, Internal medicine and Cancer.
As a member of one scientific family, Andrea Bezjak mostly works in the field of Surgery, focusing on Neoadjuvant therapy and, on occasion, Sarcoma, Soft tissue sarcoma, Randomization and Adjuvant therapy.
Her Radiation therapy research incorporates themes from Prospective cohort study and Effective dose, Nuclear medicine.
Her studies in Lung cancer integrate themes in fields like Survival rate, Supine position, Brachial plexus and Radiography.
The Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
Her Cancer research is multidisciplinary, relying on both Quality of life and Clinical trial.
Her most cited work include:
- Erlotinib in previously treated non-small-cell lung cancer. (4713 citations)
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer (1764 citations)
- Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases (462 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Lung cancer, Internal medicine, Radiation therapy, Radiology and Oncology.
She combines subjects such as Locally advanced, Medical physics, Chemoradiotherapy and Radiation treatment planning with her study of Lung cancer.
Andrea Bezjak works mostly in the field of Internal medicine, limiting it down to topics relating to Surgery and, in certain cases, Clinical trial, as a part of the same area of interest.
Her Radiation therapy research is multidisciplinary, incorporating perspectives in Stage, Prospective cohort study and Nuclear medicine.
Her research integrates issues of Tomography and Cone beam ct in her study of Nuclear medicine.
Her Lung research extends to Radiology, which is thematically connected.
She most often published in these fields:
- Lung cancer (38.98%)
- Internal medicine (35.03%)
- Radiation therapy (36.66%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (35.03%)
- Lung cancer (38.98%)
- Radiology (29.93%)
In recent papers she was focusing on the following fields of study:
Internal medicine, Lung cancer, Radiology, Oncology and Non small cell are her primary areas of study.
Her work deals with themes such as Gastroenterology and Surgery, which intersect with Internal medicine.
Her Lung cancer research is multidisciplinary, incorporating elements of Stage, Chemoradiotherapy, Radiation therapy and Nuclear medicine.
Her Radiation therapy research includes themes of Clinical trial and Intensive care medicine.
Her Radiology study integrates concerns from other disciplines, such as Esophagus and Lung.
The study incorporates disciplines such as Palliative radiotherapy, Palliative Radiation Therapy and Carcinoma in addition to Oncology.
Between 2015 and 2021, her most popular works were:
- Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial (187 citations)
- Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. (98 citations)
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. (89 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Her primary areas of investigation include Internal medicine, Lung cancer, Oncology, Esophagus and Prospective cohort study.
Her Internal medicine study frequently draws connections to other fields, such as Surgery.
She interconnects Chemoradiotherapy, Radiology, Nuclear medicine and Lung in the investigation of issues within Lung cancer.
In the subject of general Oncology, her work in non-small cell lung cancer is often linked to State, thereby combining diverse domains of study.
In her study, Gastroenterology, Radiosurgery, Cohort and Pulmonary artery is inextricably linked to Toxicity, which falls within the broad field of Esophagus.
In her research on the topic of Performance status, Survival rate and Cancer is strongly related with Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
